Abstract
Pityriasis lichenoides (PL) is an uncommon, acquired spectrum of skin conditions that poses various challenges to patients as well as clinicians. It is a difficult and debatable disorder to diagnose, categorize, and treat. Besides these inherent obstacles, PL merits awareness because of its potential to progress to cutaneous lymphoma or an ulceronecrotic presentation, both of which carry a significant risk of mortality.
The scope of PL presentations is delineated along a continuum of multiple variants including pityriasis lichenoides et varioliformis acuta (PLEVA), pityriasis lichenoides chronica (PLC), and febrile ulceronecrotic Mucha-Habermann disease (FUMHD). Classification of these presentations as separate subsets is debatable in view of their overlapping clinical, histopathologic, and etiologic features. PLEVA generally presents as an acute-to-subacute skin eruption of multiple, small, red papules that develops into polymorphic lesions and vacillates with periods of varying remissions as well as possible sequelae of hyper/hypopigmentation and varicella-like scars. PLC has a more gradual manifestation of very small red-to-brown flat maculopapules with mica-like scale; it also follows a relapsing course but with long periods of remission. FUMHD is an acute and severe generalized eruption of purpuric and ulceronecrotic plaques with associated systemic involvement and a mortality rate of up to 25%; hence, it should be approached as a dermatologic emergency.
Histopathological evaluation of PL usually reveals dermal, wedge-shaped, lymphocytic infiltrate, epidermal spongiosis, parakeratosis, and variable necrosis of keratinocytes. PLC demonstrates more subtle histology whereas, at the other end of the spectrum, febrile ulceronecrotic FUMHD exhibits the most exaggerated histological features.
The pathogenic mechanism behind PL is unclear although infectious or drug-related hypersensitivity reactions versus premycotic lymphoproliferative disorder are the mainstay theories.
Similar content being viewed by others
References
Cozzio A, Hafner J, Kempf W.: Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity? J Am Acad Dermatol 2004; 51: 1014–7
Daoud MS, Pittelkow MR.: Pityriasis lichenoides. In. Freedberg IM, Eisen AZ, Wolff Keditors. Fitzpatrick’s dermatology in general medicine. 6th edition. New York: McGraw-Hill, Inc., 2003: 456–62
Wood GS, Reizner G.: Other papulosquamous disorders.In: Bolognia JL, Jorizzo J, Rapini R, editors. Dermatology. London: CV Mosby, 2003: 151–63
Ricci G, Patrizi A, Misciali D.: Pathological case of the month: febrile Mucha-Habermann disease. Arch Pediatr Adolesc Med 2001; 155: 195–6
Lichenoides and interface dermatoses. In:McKee PH, Calonje E, Granter SR, editors. Pathology of the skin with clinical correlations. 3rd edition. London: Mosby Ltd, 2005: 217–60
Horn TD.: Inflammatory reactions in the skin. In: aiBarnhill RL. Textbook of dermatopathology. New York: McGraw-Hill, Inc, 1998: 31–54
Gelmetti C, Rigoni C, Alessi E.: Pityriasis lichenoides in children: a long term follow-up of eighty-nine cases. J Am Acad Dermatol 1990; 23: 473–8
Tsianakas A, Hoeger PH.: Transition of pityriasis lichenoides et varioliformis acuta to febrile ulceronecrotic Mucha-Habermann disease is associated with elevated serum tumor necrosis factor-alpha. Br J Dermatol 2005; 152: 794–9
Tomasini D, Zampatti C, Palmedo G.: Cytotoxic mycosis fungoides evolving from pityriasis lichenoides chronica in a seventeen-year-old girl. Dermatology 2002; 205: 176–9
Rivera R, Ortiz J, Rodriguez-Peralto L.: Febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta with atypical cells. Int J Dermatol 2003; 42: 26–8
Degos R, Duperrat B, Daniel F.: Le parapsoriasis ulceronecrotique hyperthermique. Ann Dermatol Venereol 1966; 93: 481–96
Yang C, Lee J, Chen W.: Febrile ulceronecrotic Mucha-Habermann disease with extensive skin necrosis in intertriginous areas. Eur J Dermatol 2003; 13: 493–6
Yanaba K, Ito M, Sasaki H.: A case of febrile ulceronecrotic Mucha-Habermann disease requiring debridement of necrotic skin and epidermal autograft. Br J Dermatol 2002; 147: 1249–53
Tsuji T, Kasamatsu M, Yokota M.: Mucha-Habermann disease and its febrile ulceronecrotic variant. Cutis 1996; 58: 123–31
Herron MD, Bohnsack JF, Vanderhooft SL.: Septic, CD-30 positive febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta. Pediatr Dermatol 2005; 22: 360–5
Malnar T, Milaver-Puretic V, Rados J.: Febrile ulceronecrotic pityriasis lichenoides et varioliformis acuta with fatal outcome. J Eur Acad Dermatol Venereol 2006; 20: 303–7
Miyamoto T, Takayama N, Kitada S.: Febrile ulceronecrotic Mucha-Habermann disease: a case report and a review of the literature. J Clin Pathol 2003; 56: 795–7
Patel DG, Kihiczak G, Schwartz RA.: Pityriasis lichenoides. Cutis 2000; 65: 17–20, 23
Henning JS.: Pityriasis lichenoides chronica. Dermatol Online J 2004; 10: 8
Ko J, Seong J, Suh K.: Pityriasis lichenoides-like mycosis fungoides in children. Br J Dermatol 2000; 142: 347–52
Slater DN.: The new World Health Organization-European Organization for Research and Treatment of Cancer classification for cutaneous lymphoma: a practical marriage of two giants. Br J Dermatol 2005; 153: 874–80
Varga FJ, Vonderheid EC, Olbricht SM.: Immunohistochemical distinction of lymphomatoid papulosis and pityriasis lichenoides et varioliformis acuta. Am J Pathol 1990; 136: 979–87
Panhans A, Bodemer C, Macinthyre E.: Pityriasis lichenoides of childhood with atypical CD30-positive cells and clonal T-cell receptor gene rearrangements. J Am Acad Dermatol 1996; 35: 489–90
Zlatkov NB, Adreev VC.: Toxoplasmosis and pityriasis lichenoides. Br J Dermatol 1972; 87: 114–6
Tomasini D, Tomasini CF, Cerri A.: Pityriasis lichenoides: a cytotoxic T-cell-mediated skin disorder. Evidence of human parvovirus B19 DNA in nine cases. J Cutan Pathol 2004; 31: 531–8
Boralevi F, Cotto E, Baysse L.: Is varicella zoster virus involved in the etiopathogeny of pityriasis lichenoides? J Invest Dermatol 2003; 121: 647–8
Klein PA, Jones EC, Nelson JL.: Infectious causes of pityriasis lichenoides: a case of fulminant infectious mononucleosis. J Am Acad Dermatol 2003; 49: 151–3
Tsai KS, Hsieh HJ, Chow KC.: Detection of cytomegalovirus infection in a patient with febrile ulceronecrotic Mucha-Habermann’s disease. Int J Dermatol 2001; 40: 694–8
Rongioletti F, Delmonte S, Rebora A.: Pityriasis lichenoides and acquired toxoplasmosis. Int J Dermatol 1999; 38: 372–4
Smith KJ, Nelson A, Skelton H.: Pityriasis lichenoides et varioliformis acuta in HIV-1+ patient: a marker of early stage disease. Int J Dermatol 1997; 36: 104–9
Kawamura K, Tsuji T, Kuwabara Y.: Mucha-Habermann disease-like eruptions due to tegafur. J Dermatol 1999; 26: 164–7
Hollander A, Grots IA.: Mucha-Habermann disease following estrogen-progesterone therapy. Arch Dermatol 1973; 107: 465
Stosiek N, Peters KP, Von den DrieschP.: Pityriasis-lichenoides-et-varioliformis-acuta-like drug exanthema caused by astemizole. Hautarzt 1993; 44: 235–7
Tanaka M.: Drug-induced pityriasis lichenoides et varioliformis acuta. Rinsho Hifuka 1990; 44: 307–10
Nishimura M, Matsuda T, Hori Y.: Mucha-Habermann disease resolves after tonsillectomy. Int J Dermatol 1991; 30: 896–7
Zechini B, Teggi A, Antonelli M.: A case report of pityriasis lichenoides in a patient with chronic hepatitis C. J Infect 2005; 51: e23–5
Clayton R, Haffenden G.: An immunofluorescence study of pityriasis lichenoides. Br J Dermatol 1978; 99: 491–3
Clayton R, Haffenden G, Du Vivier A.: Pityriasis lichenoides: an immune complex disease. Br J Dermatol 1977; 97: 629–34
Muhlbauer JE, Bhan AK, Harrist TJ.: Immunopathology of pityriasis lichenoides acuta. J Am Acad Dermatol 1984; 10: 783–95
Khosrotehrani K, Guegan S, Fraitag S.: Presence of chimeric maternally derived keratinocytes in cutaneous inflammatory diseases of children: the example of pityriasis lichenoides. J Invest Dermatol 2006; 126: 345–8
Dereure O, Levi E, Kadin ME.: T-cell clonality in pityriasis lichenoides et varioliformis acuta: a heteroduplex analysis of 20 cases. Arch Dermatol 2000; 136: 1483–6
Margo C, Crowson NA, Kovatich A.: Pityriasis lichenoides: a clonal T-cell lymphoproliferative disorder. Hum Pathol 2002; 33: 788–95
Weinberg JM, Kristal L, Chooback L.: The clonal nature of pityriasis lichenoides. Arch Dermatol 2002; 138: 1063–7
Black MM.: Lymphomatoid papulosis and pityriasis lichenoides: are they related? Br J Dermatol 1982; 106: 717–21
Niemczyk UM, Zollner TM, Wolter M.: The transformation of pityriasis lichenoides chronica into parakeratosis variegata in an 11-year-old girl. Br J Dermatol 1997; 137: 983–7
Panizzon RG, Speich R, Dazzi H.: Atypical manifestations of pityriasis lichenoides chronica: development into paraneoplasia and non-Hodgkin lymphoma of the skin. Dermatology 1992; 184: 65–9
Fortson JS, Schroeter AL, Esterly NB.: Cutaneous T-cell lymphoma (parapsoriasis en plaque): an association with pityriasis lichenoides et varioliformis acuta in young children. Arch Dermatol 1990; 126: 1449–53
Wenzel J, Gutgemann I, Distelmaier M.: The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoides. J Am Acad Dermatol 2005; 53: 422–7
Dupont C.: Pityriasis lichenoides in a family. Br J Dermatol 1995; 133: 338–9
Garcia B, Connelly EA, Newbury R.: Pityriasis lichenoides and idiopathic thrombocytopenia purpura in a young girl. Pediatr Dermatol 2006; 23: 21–3
Kempf W, Kutzner H, Kettelhack G.: Paraneoplastic pityriasis lichenoides in cutaneous lymphoma: a case report and review of the literature on paraneoplastic reactions of skin in lymphoma and leukemia. Br J Dermatol 2005; 152: 1327–31
Brazzini B, Ghersetich I, Urso C.: Pityriasis lichenoides et varioliformis acuta during pregnancy. J Eur Acad Dermatol Venereol 2001; 15: 458–60
Eskandar MA.: Pityriasis lichenoides et varioliformis acuta in pregnancy. Saudi Med J 2001; 22: 1127–9
Milligan A, Johnston G.: Pityriasis lichenoides chronica and pityriasis lichenoides et varioliformis acuta. In: Lebwohl M, Berth-Jones J, Heymann WR, editors. Treatment of skin disease. London: CV Mosby, 2002: 472–7
Pinton PC, Capezzera R, Zane C.: Medium-dose ultraviolet A1 therapy for pityriasis lichenoides et varioliformis acuta and pityriasis lichenoides chronica. J Am Acad Dermatol 2002; 47: 410–4
Tay YK, Morelli JG, Weston WL.: Experience with UVB phototherapy in children. Pediatr Dermatol 1996; 13: 406–9
Pavlotsky F, Baum S, Barzilai A.: UVB therapy of pityriasis lichenoides: our experience with 29 patients. J Eur Acad Dermatol Venereol 2006; 20: 642–7
Luberti AA, Rabinowitz LG, Ververeli KO.: Severe febrile Mucha-Habermann’s disease in children: case report and review of the literature. Pediatr Dermatol 1991; 8: 51–7
Maekawa Y, Nakamura T, Nogami R.: Febrile ulceronecrotic Mucha-Habermann’s disease. J Dermatol 1994; 21: 46–9
Griffiths JK.: Successful long-term use of cyclosporin A in HIV-induced pityriasis lichenoides chronica. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 18: 396–7
Simon D, Boudny C, Nievergelt H.: Successful treatment of pityriasis lichenoides with topical tacrolimus. Br J Dermatol 2004; 150: 1033–5
Ito N, Ohshima A, Hashizume H.: Febrile ulceronecrotic Mucha-Habermann’s disease managed with methylprednisolone semipulse and subsequent methotrexate therapies. J Am Acad Dermatol 2003; 49: 1142–8
Nakamura S, Nishihara K, Nakajima K.: Febrile ulceronecrotic Mucha-Habermann’s disease and its successful therapy with DDS. J Dermatol 1989; 13: 381–4
Suarez J, Lopez B, Villalba R.: Febrile ulceronecrotic Mucha-Habermann disease: a case report and review of the literature. Dermatology 1996; 192: 277–9
Acknowledgments
No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of this review.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khachemoune, A., Blyumin, M.L. Pityriasis Lichenoides. Am J Clin Dermatol 8, 29–36 (2007). https://doi.org/10.2165/00128071-200708010-00004
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128071-200708010-00004